HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 342 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,952,000 | +10.8% | 65,000 | +1.7% | 0.04% | +12.9% |
| Q1 2021 | $2,664,000 | +224.5% | 63,900 | +232.3% | 0.03% | +210.0% |
| Q4 2020 | $821,000 | +62.3% | 19,232 | 0.0% | 0.01% | +42.9% |
| Q3 2020 | $506,000 | -77.7% | 19,232 | -77.2% | 0.01% | -78.1% |
| Q2 2020 | $2,264,000 | +48.4% | 84,433 | -0.4% | 0.03% | +33.3% |
| Q1 2020 | $1,526,000 | -6.0% | 84,806 | -5.5% | 0.02% | +50.0% |
| Q4 2019 | $1,624,000 | +15.2% | 89,706 | -1.3% | 0.02% | +6.7% |
| Q3 2019 | $1,410,000 | -9.7% | 90,902 | 0.0% | 0.02% | -11.8% |
| Q2 2019 | $1,562,000 | +3.9% | 90,902 | -2.6% | 0.02% | +6.2% |
| Q1 2019 | $1,503,000 | +10.0% | 93,302 | 0.0% | 0.02% | -11.1% |
| Q4 2018 | $1,366,000 | -19.4% | 93,302 | 0.0% | 0.02% | +12.5% |
| Q3 2018 | $1,695,000 | +7.7% | 93,302 | 0.0% | 0.02% | 0.0% |
| Q2 2018 | $1,574,000 | -13.9% | 93,302 | 0.0% | 0.02% | -15.8% |
| Q1 2018 | $1,828,000 | -12.2% | 93,302 | -9.2% | 0.02% | -5.0% |
| Q4 2017 | $2,081,000 | +23.4% | 102,706 | +5.8% | 0.02% | +42.9% |
| Q3 2017 | $1,686,000 | +35.5% | 97,061 | 0.0% | 0.01% | +27.3% |
| Q2 2017 | $1,244,000 | -3.8% | 97,061 | -2.7% | 0.01% | 0.0% |
| Q1 2017 | $1,293,000 | +31.3% | 99,746 | 0.0% | 0.01% | +37.5% |
| Q4 2016 | $985,000 | -18.3% | 99,746 | 0.0% | 0.01% | -11.1% |
| Q3 2016 | $1,205,000 | +38.8% | 99,746 | -0.8% | 0.01% | +28.6% |
| Q2 2016 | $868,000 | -8.8% | 100,573 | 0.0% | 0.01% | -22.2% |
| Q1 2016 | $952,000 | -57.3% | 100,573 | -21.7% | 0.01% | -59.1% |
| Q4 2015 | $2,227,000 | +57.9% | 128,491 | +22.4% | 0.02% | +46.7% |
| Q3 2015 | $1,410,000 | -60.2% | 104,979 | -33.1% | 0.02% | -65.9% |
| Q2 2015 | $3,542,000 | +136.1% | 156,879 | +49.4% | 0.04% | +158.8% |
| Q1 2015 | $1,500,000 | +47.9% | 104,979 | 0.0% | 0.02% | +41.7% |
| Q4 2014 | $1,014,000 | – | 104,979 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
| First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
| SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
| Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
| Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
| Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
| DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
| Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
| Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |